The U.S. Food and Drug Administration (FDA) announced that it has approved Ultresa™ delayed-release capsules, a pancreatic enzyme replacement therapy. Ultresa (pancrelipase) is manufactured by Aptalis Pharma.
Site Search
Showing 371 - 380 of 404 results
News
|
Oct. 22, 2012
|
2 min read
News
|
March 2, 2012
|
1 min read
News
|
Aug. 31, 2012
|
2 min read
The European Medicines Agency (EMA) announced today that it has recommended the approval of the CF drug Kalydeco™ for people with the G551D mutation ages 6 and older in the European Union.
News
|
May 25, 2012
|
2 min read
News
|
Oct. 25, 2012
|
2 min read
News
|
April 19, 2012
|
3 min read
News
|
Dec. 21, 2012
|
3 min read
News
|
Aug. 31, 2012
|
1 min read
News
|
Feb. 6, 2017
|
1 min read
As an adult with cystic fibrosis, I know just how powerful and creative the CF community can be. That's why I'm excited to announce the four 2017 Impact Grant awardees who are making a positive impact on the CF community.
Piper Beatty Welsh, J.D., M.P.A.
|
4 min read